financetom
Business
financetom
/
Business
/
MetLife Q2 Adjusted Earnings, Revenue Decline; Shares Fall After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MetLife Q2 Adjusted Earnings, Revenue Decline; Shares Fall After Hours
Aug 6, 2025 1:59 PM

04:37 PM EDT, 08/06/2025 (MT Newswires) -- MetLife ( MET ) reported Q2 adjusted earnings Wednesday of $2.02 per diluted share, down from $2.28 a year earlier.

Analysts polled by FactSet expected $2.15.

Revenue for the quarter ended June 30 was $17.34 billion, down from $17.82 billion a year earlier.

Analysts surveyed by FactSet expected $18.53 billion.

The company's shares were down nearly 5% in after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Australia's Telix Pharma says FDA seeks more data on cancer diagnostic drug; shares plunge
Australia's Telix Pharma says FDA seeks more data on cancer diagnostic drug; shares plunge
Aug 28, 2025
Aug 28 (Reuters) - The U.S. Food and Drug Administration (FDA) sought more data from Telix Pharmaceuticals ( TLX ) on its drug to detect a form of kidney cancer, the Australian cancer diagnostics firm said on Thursday. Telix's Sydney-listed shares plunged as much as 24%, its worst intraday fall on record. It ended 18.8% lower at A$14.95 and was...
Berkshire raises stake in Japan's Mitsubishi above 10%
Berkshire raises stake in Japan's Mitsubishi above 10%
Aug 28, 2025
TOKYO, Aug 28 (Reuters) - Berkshire Hathaway ( BRK/A ), through its wholly-owned unit National Indemnity Company, has raised its stake in Japan's Mitsubishi Corp ( MSBHF ) and Mitsui & Co ( MITSF ) , the companies said on Thursday. Berkshire raised its stake in Mitsubishi ( MSBHF ) to 10.23% from 9.74% previously, the company said in a...
Cel-Sci Prices $10 Million Stock Offering
Cel-Sci Prices $10 Million Stock Offering
Aug 28, 2025
03:22 AM EDT, 08/28/2025 (MT Newswires) -- Cel-Sci ( CVM ) said late Wednesday it priced a public offering of about 1.1 million common shares at $9 per share for expected gross proceeds of about $10 million. Net proceeds will be used for the company's drug development program, working capital and general corporate purposes, it said. Closing of the offering...
Why Is CEL-SCI Stock Crashing After-Hours?
Why Is CEL-SCI Stock Crashing After-Hours?
Aug 28, 2025
CEL-SCI Corporation ( CVM ) shares tumbled 38.19% in after-hours trading to $8.06 on Tuesday following the cancer immunotherapy company’s announcement of a $10 million public offering priced below current market levels. Check out the current price of CVM stock here.  Offering Details Drive Share Price Volatility The clinical-stage company priced 1,111,200 common shares at $9.00 each, representing a 30.9%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved